Shares of Midatech Pharma plc (LON:MTPH – Get Rating) passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of GBX 9.83 ($0.12) and traded as high as GBX 11.88 ($0.14). Midatech Pharma shares last traded at GBX 11.50 ($0.14), with a volume of 200,432 shares trading hands.
Midatech Pharma Trading Up 2.2 %
The company has a quick ratio of 6.06, a current ratio of 6.39 and a debt-to-equity ratio of 7.33. The firm has a market cap of £11.33 million and a price-to-earnings ratio of -1.69. The business has a 50 day moving average price of GBX 9.83 and a 200-day moving average price of GBX 11.56.
About Midatech Pharma
Midatech Pharma plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTD219, a long-acting formulation of tacrolimus used to lower the risk of organ transplant rejection.
Recommended Stories
- 2 EV Suppliers Powering To Gains After Raising Views
- Applied Materials Results Show A Slowing Semiconductor Market
- MarketBeat: Week in Review 8/15 – 8/19
- Near-Term Headwinds Present An Opportunity In Ross Stores
- Apple’s Stock Could Be On The Verge Of Another 30% Rally
Receive News & Ratings for Midatech Pharma Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Midatech Pharma and related companies with MarketBeat.com’s FREE daily email newsletter.